Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells
Stephanie Ferreira1, Ruben Fernandes1,2, Monica C Botelho2,3
1Escola Superior de Saúde, Instituto Politécnico do Porto, Portugal.
Background:
Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
Methods:
Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent. We observed unexpected death of these cells when treated with F. hepatica extracts.
Results:
We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Insights
Fasciola hepatica extracts unexpectedly killed cancer cells in lab tests. This discovery suggests the parasite could potentially be developed for novel cancer therapies, offering new hope for treating liver cancer.
Area of Science:
- Parasitology
- Cancer Biology
- Drug Discovery
Background:
- Fascioliasis, caused by liver flukes like *Fasciola hepatica*, is a neglected tropical disease affecting millions globally.
- While other liver flukes (*O. viverrini*, *C. sinensis*) are linked to cholangiocarcinoma, *F. hepatica* has not been associated with cancer.
- No known causative link exists between *F. hepatica* infection and liver cancer (cholangiocarcinoma).
Purpose of the Study:
- To investigate the biological effects of *Fasciola hepatica* extracts on mammalian cells.
- To explore the potential of *F. hepatica* as a novel therapeutic agent in cancer treatment.
Main Methods:
- Chinese Hamster Ovary (CHO) cells were exposed to *F. hepatica* extracts.
- Cell proliferation was quantified using an MTS assay measuring mitochondrial activity.
- Observed cytotoxic effects of the parasite extracts on cancer cells were documented.
Main Results:
- *Fasciola hepatica* extracts induced significant cell death in treated CHO cells.
- Unexpectedly high mortality rates were observed, indicating potent cytotoxic properties.
- The study identified a novel anti-cancer effect of *F. hepatica*.
Conclusions:
- The cytotoxic effects of *F. hepatica* extracts on cancer cells warrant further investigation.
- This parasite shows potential as a source for developing new cancer therapies.
- Further research could establish *F. hepatica* as a medically significant trematode pathogen for cancer treatment.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Adult Stem Cells
What is Cell Signaling?

